CALL

400-6813-863

News
Exhibition Review | 2024 Polypeptide Innovative Drug Development Forum Successfully Ends

Peptides are molecules composed of amino acids as the basic unit, with a molecular weight generally below 10 kDa, between small chemical molecules and biological products. Compared with traditional small molecule drugs and protein drugs, peptide drugs have the following characteristics: ① high specificity and multiple new targets; ② Good safety, not easy to accumulate; ③ Easy to synthesize and modify; ④ Low immunogenicity; ⑤ Difficulty in oral administration; ⑥ Low dosage and difficult analysis.

With the maturity of biotechnology and peptide synthesis technology, more and more peptide drugs have been developed and widely used in the prevention, diagnosis and treatment of cancer, hepatitis, diabetes, AIDS and other diseases, with a broad market space.

Therefore, the "2024 Peptide Innovation Drug Development Forum" invited multiple experts and scholars in the field of peptide drug development to conduct in-depth discussions and exchanges on topics such as cutting-edge peptide research and drug development, preparation processes, and cutting-edge peptide research and drug development in Shenzhen from March 21 to 22, 2024.

As one of the sponsors of this conference, Premedlab has carefully prepared and brought a fully upgraded fully automatic solid-phase peptide synthesizer to participate in this exhibition. We will exchange ideas with experts and teachers, and Premedlab hopes to contribute to the research of peptide drugs.

6.jpg


Tel:

400-6813-863